id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-D-0745-0001,FDA,FDA-2022-D-0745,Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request,Notice,Notice of Availability,2022-06-16T04:00:00Z,2022,6,2022-06-16T04:00:00Z,,2023-10-20T15:30:52Z,2022-12928,0,0,090000648516ddf3
FDA-2022-D-0745-0002,FDA,FDA-2022-D-0745,Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies; Draft Guidance for Industry,Other,Guidance,2022-06-16T04:00:00Z,2022,6,2022-06-16T04:00:00Z,2022-09-15T03:59:59Z,2023-11-28T19:57:36Z,,0,0,090000648516e048